Page 10 - Biogenics Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biogenics ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biogenics Ltd Today - Breaking & Trending Today

Weekly Analysts' Ratings Changes for Vascular Biogenics (VBLT)

Vascular Biogenics (NASDAQ: VBLT) recently received a number of ratings updates from brokerages and research firms: 5/15/2022 – Vascular Biogenics is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 5/7/2022 – Vascular Biogenics is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 4/29/2022 […] ....

Or Yehuda , Tel Aviv , United States , Goldman Sachs Group Inc , Zacks Investment Research , Vascular Biogenics Ltd , Envestnet Asset Management Inc , Spectrum Planning Advisory Services Inc , Vascular Biogenics , Get Rating , Sigma Advisers , Advisory Services , Sachs Group , Street Group , Envestnet Asset Management , Biogenics Ltd , Nasdaq Vblt ,

Vascular Biogenics Ltd. (NASDAQ:VBLT) Sees Significant Increase in Short Interest

Vascular Biogenics Ltd. (NASDAQ:VBLT – Get Rating) was the recipient of a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 688,000 shares, a growth of 32.4% from the April 15th total of 519,500 shares. Currently, 1.5% of the company’s shares are short sold. Based […] ....

United States , Northern Trust Corp , Zacks Investment Research , Vascular Biogenics Ltd , Vascular Biogenics Company Profile Get Rating , Advisor Group Holdings Inc , Envestnet Asset Management Inc , Vascular Biogenics , Get Rating , Investment Research , Chardan Capital , Group Holdings , Asset Management , Point Capital , Biogenics Company Profile , Biogenics Ltd , Nasdaq Vblt ,

Vascular Biogenics Ltd. (NASDAQ:VBLT) Given Consensus Recommendation of "Buy" by Brokerages

Shares of Vascular Biogenics Ltd. (NASDAQ:VBLT – Get Rating) have been assigned an average recommendation of “Buy” from the six analysts that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have given a buy recommendation […] ....

United States , Northern Trust Corp , Harel Insurance Investments Financial Services Ltd , Zacks Investment Research , Altshuler Shaham Ltd , Vascular Biogenics Ltd , Vascular Biogenics Company Profile Get Rating , Vascular Biogenics , Get Rating , Marketbeat Ratings , Investment Research , Chardan Capital , Point Capital , Shaham Ltd , Insurance Investments , Financial Services , Biogenics Company Profile , Biogenics Ltd , Nasdaq Vblt ,

Brokerages Expect Vascular Biogenics Ltd. (NASDAQ:VBLT) Will Announce Quarterly Sales of $200,000.00

Wall Street analysts expect Vascular Biogenics Ltd. (NASDAQ:VBLT – Get Rating) to report $200,000.00 in sales for the current quarter, Zacks reports. Three analysts have provided estimates for Vascular Biogenics’ earnings. The lowest sales estimate is $190,000.00 and the highest is $200,000.00. Vascular Biogenics reported sales of $190,000.00 during the same quarter last year, which […] ....

United States , Northern Trust Corp , Harel Insurance Investments Financial Services Ltd , Zacks Investment Research , Vascular Biogenics Ltd , Vascular Biogenics Company Profile Get Rating , Spectrum Planning Advisory Services Inc , Wall Street , Vascular Biogenics , Get Rating , Vascular Biogenic , Investment Research , Point Capital , Trust Corp , Insurance Investments , Financial Services , Spectrum Planning , Advisory Services , Biogenics Company Profile , Biogenics Ltd , Nasdaq Vblt ,

Weekly Research Analysts' Ratings Updates for Vascular Biogenics (VBLT)

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock. ....

Or Yehuda , Tel Aviv , United States , Goldman Sachs Group Inc , Zacks Investment Research , Vascular Biogenics Ltd , Millennium Management , Spectrum Planning Advisory Services Inc , Vascular Biogenics , Get Rating , Sigma Advisers , Advisory Services , Sachs Group , Street Group , Biogenics Ltd ,